Literature DB >> 3838583

Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant.

M Hallman, G Enhorning, F Possmayer.   

Abstract

The possibility that pulmonary surfactant, characterized by a phosphatidylglycerol deficiency, as in early fetal life, might have inferior surface properties was evaluated. We obtained this specific surfactant from adult rabbits by withholding glucose and giving them an excess of myoinositol by mouth and intravenously. Controls were given a similar quantity of glucose. The myoinositol resulted in a drastic reduction of surfactant phosphatidylglycerol, from 7.2 to 0.3% of phospholipids, and a corresponding increase in phosphatidylinositol from 4.8 to 11.3%. In addition, the myoinositol treatment increased the myoinositol that was disaturated from 18.5 to 27.3% (p less than 0.05). The corresponding figures for disaturated phosphatidyl-choline were 56.0 and 60.5%, respectively (NS). The myoinositol treatment for 4 days increased the pool size of alveolar surfactant by 32% (p less than 0.01). The surface activity was studied with modified Wilhelmy balance and the pulsating bubble surfactometer. Surfactant containing phosphatidylinositol rather than phosphatidylglycerol was not inferior, as compared to surfactant that contained phosphatidylglycerol (minimum surface tension: 2.0 versus 2.2 mN X m-1; collapse rate at 10 nM X m-1: 1.85 versus 1.95 min-1; rate of adsorption from subphase to surface: 32 versus 35 mN X m-1 X 30 s-1), nor was there a difference in the ability of the two surfactants to improve lung stability of 27-day-old rabbit fetuses (air retention at 35 cm H2O: 1.8 versus 1.8 ml/30 g; air retention at 0 cm H20: 0.8 versus 0.9 ml/30 g). We conclude that phosphatidylinositol surfactant does not have inferior surface properties.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838583     DOI: 10.1203/00006450-198503000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

1.  Structure and function of phosphatidylglycerol-deficient lung surfactant.

Authors:  J E Bleasdale; J M Snyder; R L Johnson
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

3.  Alveolar type II cell response in rats exposed to aerosols of alpha-cristobalite.

Authors:  R B Low; K O Leslie; D R Hemenway; M Absher; K B Adler; M S Giancola; P M Vacek
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

4.  Studies on the formation of dipalmitoyl species of phosphatidylcholine and phosphatidylethanolamine in pulmonary type II cells.

Authors:  B Rüstow; M Schlame; R Haupt; D Wilhelm; D Kunze
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

5.  Respiratory distress syndrome and inositol supplementation in preterm infants.

Authors:  M Hallman; A L Järvenpää; M Pohjavuori
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 6.  Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications.

Authors:  Gianfranca Carta; Elisabetta Murru; Sebastiano Banni; Claudia Manca
Journal:  Front Physiol       Date:  2017-11-08       Impact factor: 4.566

7.  Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry.

Authors:  Srikanth Karnati; Vannuruswamy Garikapati; Gerhard Liebisch; Paul P Van Veldhoven; Bernhard Spengler; Gerd Schmitz; Eveline Baumgart-Vogt
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

8.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.